AFP and hepatocellular carcinoma: Shian et al. reported that HCC patients who expressed high levels of AFP (> 200 ng/ml) had larger tumour diameters (> 5 cm), increased pathological grading (II–IV), and increased portal invasion (IIIA–IV HCC) than those who expressed low levels of AFP (< 200 ng/ml).